Ipilimumab and a poxviral vaccine targeting prostate-specific antigen in metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial (Q83427167)
Jump to navigation
Jump to search
scientific article published on 10 February 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Ipilimumab and a poxviral vaccine targeting prostate-specific antigen in metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial |
scientific article published on 10 February 2012 |
Statements
Ipilimumab and a poxviral vaccine targeting prostate-specific antigen in metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial (English)
Jeffrey Schlom
Ravi A Madan
Mahsa Mohebtash
Philip M Arlen
Matteo Vergati
Myrna Rauckhorst
Seth M Steinberg
Kwong Y Tsang
Diane J Poole
Howard L Parnes
John J Wright
William L Dahut
10 February 2012
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference